Press Releases for the Psychedelics Industry

Psychedelics News

Press Releases

4 Oct 2020

MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines

NEW YORK, Oct....

By Microdose

Press Releases

23 Sep 2020

MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin

BASEL, Switzerland, Sept....

By Microdose

Press Releases

22 Sep 2020

COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares

COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares Read more on Microdose...

By Microdose

Press Releases

20 Sep 2020

MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor

NEW YORK, Sept....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

24 Aug 2020

MindMed Announces First-Ever Clinical Trial Combining MDMA and LSD

NEW YORK, Aug....

By Microdose

Press Releases

13 Aug 2020

Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results

Reports Strong Cash Position of $24m USD To Execute Multiple Clinical Trials New York, – August 14, 2020 – Mind Medicine (MindMed) Inc....

By Microdose

Press Releases

12 Aug 2020

MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President

BASEL, Switzerland, Aug....

By Microdose

Press Releases

5 Aug 2020

MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy

Applauds Health Canada’s Approval Of Psilocybin Compassionate Access For Patients New York, NY, August 6, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc....

By Microdose

Press Releases

27 Jul 2020

MindMed Completes Dosing 18-MC Phase 1 Study

Company, seeing early success, will advance preparations for Phase 2a clinical trial in opioid addiction New York, NY, July 28, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result